Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Timor-Leste
Timor-Leste: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 1.0% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Timor-Leste, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Timor-Leste stood at 1.0%. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 28.6% on the previous year and down 69.7% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Timor-Leste peaked at 3.3% in 2015 and was at its lowest, 1.0%, in 2024.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Timor-Leste, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 3.3% | — |
| 2016 | 2.8% | -15.2% |
| 2017 | 2.3% | -17.9% |
| 2018 | 2.1% | -8.7% |
| 2019 | 1.8% | -14.3% |
| 2020 | 1.5% | -16.7% |
| 2021 | 1.4% | -6.7% |
| 2022 | 1.4% | +0.0% |
| 2023 | 1.4% | +0.0% |
| 2024 | 1.0% | -28.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.5% | 1.8% | 3.3% | 5 |
| 2020s | 1.3% | 1.0% | 1.5% | 5 |
Countries ranked near Timor-Leste
More development goals data for Timor-Leste
- Red List Index 0.8585 (2025)
- Number of refugees per 100,000 population, by country of origin 1.13 (2025)
- Manufacturing value added per capita 21.95 (2025)
- Infant deaths 1,051 (2024)
- Neonatal deaths 659 (2024)
- Alcohol consumption per capita (aged 15 years and older) within a 0.2022 (2024)
- Under-five deaths 1,449 (2024)
- Children moderately or severely stunted 69.1 (2024)
- Children moderately or severely overweight 1.8 (2024)
- Domestic material consumption, by type of raw material 6.35 million (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Timor-Leste?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Timor-Leste was 1.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Timor-Leste?
- The highest recorded value was 3.3% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Timor-Leste?
- The lowest recorded value was 1.0% in 2024.
- How does Timor-Leste rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Timor-Leste ranks 3rd out of 15 regions with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Timor-Leste?
- Over the last ten years it is down 69.7%. The long-run trend across the full record is falling.
- Where does this Timor-Leste data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).